Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001698
Filing Date
2025-08-12
Accepted
2025-08-12 16:02:25
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20250630x10q.htm   iXBRL 10-Q 1465485
2 EX-10.1 atxs-20250630xex10d1.htm EX-10.1 80199
3 EX-31.1 atxs-20250630xex31d1.htm EX-31.1 11279
4 EX-31.2 atxs-20250630xex31d2.htm EX-31.2 11220
5 EX-32.1 atxs-20250630xex32d1.htm EX-32.1 6293
  Complete submission text file 0001410578-25-001698.txt   6606272

Data Files

Seq Description Document Type Size
6 EX-101.SCH atxs-20250630.xsd EX-101.SCH 42478
7 EX-101.CAL atxs-20250630_cal.xml EX-101.CAL 40854
8 EX-101.DEF atxs-20250630_def.xml EX-101.DEF 180084
9 EX-101.LAB atxs-20250630_lab.xml EX-101.LAB 396200
10 EX-101.PRE atxs-20250630_pre.xml EX-101.PRE 282748
71 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20250630x10q_htm.xml XML 1181150
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 251206513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)